What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Asthma
- Gene
His primary areas of investigation include Asthma, Internal medicine, Immunology, Anesthesia and Bronchodilator.
Stephen P. Peters specializes in Asthma, namely Salmeterol.
His Internal medicine study deals with Endocrinology intersecting with Interleukin 4, Cytokine, Interleukin and Interleukin 13.
His Immunology research is multidisciplinary, incorporating perspectives in Biomarker, Bronchial hyperresponsiveness, Airway and Myofibroblast.
As a member of one scientific family, Stephen P. Peters mostly works in the field of Anesthesia, focusing on Crossover study and, on occasion, Gastroenterology, Intention-to-treat analysis, Respimat, Tiotropium bromide and Glucocorticoid.
His studies deal with areas such as Morning and Inhalation as well as Bronchodilator.
His most cited work include:
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program (1383 citations)
- Proceedings of the ATS Workshop on Refractory Asthma Current Understanding, Recommendations, and Unanswered Questions (771 citations)
- Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program (702 citations)
What are the main themes of his work throughout his whole career to date?
Stephen P. Peters spends much of his time researching Asthma, Immunology, Internal medicine, COPD and Intensive care medicine.
His research on Asthma focuses in particular on Bronchodilator.
His Immunology study integrates concerns from other disciplines, such as Bronchoalveolar lavage and Lung.
His research integrates issues of Gastroenterology and Endocrinology in his study of Internal medicine.
The study incorporates disciplines such as Pulmonary disease and Spirometry in addition to COPD.
His research in Intensive care medicine intersects with topics in Disease and MEDLINE.
He most often published in these fields:
- Asthma (51.35%)
- Immunology (34.53%)
- Internal medicine (34.53%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (34.53%)
- COPD (11.71%)
- Asthma (51.35%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, COPD, Asthma, Cohort and Exacerbation.
His Internal medicine study incorporates themes from Gastroenterology, Airway and Cardiology.
His COPD research includes themes of Body mass index, Odds ratio, Pulmonary disease, FEV1/FVC ratio and Spirometry.
His research on Asthma concerns the broader Immunology.
His study in Cohort is interdisciplinary in nature, drawing from both Framingham Risk Score, Disease, Risk of mortality, Incidence and Respiratory system.
The Exacerbation study combines topics in areas such as Heart failure, Coronary artery disease, Relative risk, Myocardial infarction and Vitamin D and neurology.
Between 2017 and 2021, his most popular works were:
- Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations (70 citations)
- Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma (47 citations)
- Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level (46 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Asthma
His main research concerns Internal medicine, COPD, Asthma, Cohort and Lung.
His work deals with themes such as Endocrinology, Permissive and Polymorphism, which intersect with Internal medicine.
Stephen P. Peters combines subjects such as Pulmonary disease, Chronic bronchitis, Odds ratio and Spirometry with his study of COPD.
His study on Asthma is covered under Immunology.
The concepts of his Immunology study are interwoven with issues in Moraxella and Corynebacterium.
He has included themes like Inhalation, Pulmonology, Locus and Pathology in his Lung study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
